Oncology Rounds

The latest news and research on cancer care from the Oncology Roundtable.

How to help the 20% of cancer patients experiencing PTSD symptoms

by Deirdre Saulet and Soleil Shah February 9, 2018

Mental distress experienced before or after a cancer diagnosis can actually decrease patients' chances of survival. A new study published in Cancer looked at the prevalence of post-traumatic stress disorder (PTSD) among cancer patients. Keep reading to see what they found and how your cancer program can help.

Read more »

5 ways providers need to respond to payers' new patient assistance program approach

by Lindsay Conway January 30, 2018

As drug prices rise, a growing portion of infusion center patients have come to rely on drug manufacturers' patient assistance programs (PAPs). The aim of these programs is to ensure that patients can afford their drugs, regardless of their out-of-pocket cost. While PAPs take many forms, most offset or completely cover patients' copay, coinsurance, or deductible for drugs. 

Read more »

Growing your navigator program? Read this first.

by Deirdre Saulet and Mallory Kirby January 16, 2018

One of the most common requests we receive from cancer program leaders is for evidence on the benefits of navigation. 

To help you evaluate the benefits of navigation or to make the case for navigators at your facility, we've compiled a summary of recent studies on patient navigation and their findings here. The big takeaway is that while most of us in cancer care realize how much it can impact the patient experience, there's not much research that provides strong evidence for navigation—but programs can still learn from the results of studies to date.

Read more »

340B, drug administration packaging, and other changes impacting cancer programs in the HOPPS 2018 Final Rule

by Deirdre Saulet and Kate Wister January 3, 2018

CMS has projected an overall increase in hospital outpatient department (HOPD) payments of 1.4% from 2017. However, a significant reduction in reimbursement of 340B drugs and drug packaging changes have left many oncology programs concerned about their revenues for the 2018 calendar year. Read on to learn more about these changes and other HOPPS updates impacting cancer care.

Read more »

Our top 10 oncology quick reads of 2017

by Deirdre Saulet December 19, 2017

A lot has happened this year. To catch up on some of the biggest cancer-related news stories, we've pulled together our top 10 blogs of 2017.

Read more »

ICYMI: A fight over the future of 340B and big strides in precision medicine

by Deirdre Saulet November 20, 2017

This can be the most wonderful—and most hectic—time of the year, so it's understandable if you've fallen behind in your inbox. To help you keep up, here are the biggest news stories for cancer programs from the past month.

Read more »

Medical marijuana: The oncology drug you’re not talking about, but should

By Deirdre Saulet and Kate Wister November 8, 2017

Today, more than half of U.S. states have legalized medical marijuana and eight states—along with Washington, D.C.—allow for recreational use. But at the national-level, marijuana remains a Schedule 1 drug, severely limiting the research capabilities of scientists attempting to assess its health effects.

Many physicians are hesitant to discuss and/or recommend cannabis to their patients, not knowing how the legal landscape might change and not fully understanding its medical benefits and risks. Despite a paucity of research, more states continue to legalize medical marijuana and more cancer patients are using the drug to help manage their symptoms.

Read more »

Chemo cold caps: What you need to know

by Deirdre Saulet and Ashley Riley October 25, 2017

We've gotten an increasing number of questions about using cooling caps to reduce chemotherapy-related hair loss, which is estimated to impact nearly two-thirds of patients.

Although manual cold caps have been around for a while, machine cooling cap systems were only recently approved by the FDA. DigniCap Scalp Cooling System was the first to receive approval in 2015, followed by Paxman Scalp Cooling System in early 2017. However, the approved use of these systems had been limited to breast cancer patients—until now.

Read more »